George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’. Watch the video here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Well Nuvec is certainly not dead then! Seems like they’ve been very busy, dual loading and delivering siRNA successfully. More investigation required though to fine tune its effectiveness when dual rather than single loaded.
It was never going to be easy. I think that’s an encouraging update. Should hopefully persuade buyers from this very low level.
Don’t wish to sound negative but year end is approaching - let’s see what happens
I'm not holding my breath
Been along time coming , but there's alot of positives in the RNS !!!
It's working and showing results 💪 ,,, if this doesn't see a big blue day nothing will .....
Well, let's see what these two companies can deliver.
They should deliver something with all the stuff going on.
0.71p today. The lowest ever share price for N4P since it listed on AIM. That's some going. Over 30p a share to 0.71. History very much repeating itself I see from NT's previous AIM plc. Still the pension pot will have been topped up, the mortgage paid off etc
Well filled my details and holding information into “Hub” …Are plan’s afoot or is it just a means to placate frustrated investors?..
He’d need to sell a million shares to buy her a christmas card at the moment. I think if you look across the pond to see what the Americans are spending on Nanotech, you can see the potential. It is a bit of a race against time and there seem to be many variants on drug delivery systems in different stages of progress. Got to be in it to win it as they say. It is high risk. Nanogeniics was a brilliant punt. Just a question of how much money its going to need and where the finance is expected ti come from. N4p is so cheap now the market is barely valuing the cash never mind the technology. High risk, high reward. It might be the cheapest its ever been, but in many ways its much closer to achieving its goals than it has ever been.
Massive drop !!! Nigel must of brought a hell of an Xmas prezzie for the wife !!!
Flecced good and proper !!!!
I don’t think they would get another placing away at this price which they have already said. Nanogenics looks a better investment as they are looking to get to clinical trials in 2025, before Nuvec
They have nothing just a load of bull from Nigel other placing coming .
Wonder if they might be fishing for direct investment in nanogenics. Would’nt say no actually.
I’ve signed up. God knows why they need a strong password. Is someone likely to brake into my account and ask silly questions about fiat punto company car, or buy me some share on the cheap maybe? I think its a good idea. Much better than releasing an rns about setting up a hub. Can I pick up my amazon purchases from there?
I can understand investor communication has been poor because they have a lack of info to pass on, a boost in this will be greatly appreciated.
I just can't see them getting back to investors when even now you hardly ever get a reply, so i assume an investor relations individual will be responding which they'll only be able to regurgitate the RNS content we already have to hand. Waste of resources and money in my opinion. We need a Nuvec in vivo status update. if its running late for any reason, just say..
Also some transparency on MTA's, the MTA questions i submitted before the last prensation was swerved!.
Exactly Drutor, a complete waste of time and money. Concerning if this is the only material development happening
Why are they working on stuff like this. Twitter is free that's all we need. Hate to know how much money they wasted on this crap.
Was put out to stop the SP going to zero.
So disappointed.
Give it a rest bumble head
Not worthy of RNS. If Investor Hub is all the news N4P have to offer, it shows how little progress has been made in commercialising one deal with a Pharma Co. He promised many of us LTH a lot. Delivered an Investor Hub. Disappointed and I will not be engaging on it. BUY SHARES NIGEL
I was invested in Oxford Pharmascience, which Nigel was CEO of. He might well pull a rabbit out of the hat for N4P shareholders. Who knows? All I have seen with N4P is a repeat of what happened with Oxford Pharmascience. Lots of hype but a gradual decline in the share price. N4P has gone from over 25p in June 2018 to sub 1 p today. I hope he delivers this time around.
Well this at least implies we will soon have more to talk about.
Can't be a bad thing,.
Basel that is no big deal. Plenty of small pharmas do not work out.
I was invested in Oxford Pharmascience, which NT, was CEO of. Nigel might pull a rabbit out of the hat for N4P shareholders. Who knows? All I have seen with
the oxford pharmascience story was not good for investors. it delisted. dyor. see additional info on nigel theobald at comapnies house:
https://find-and-update.company-information.service.gov.uk/officers/kadq_ai0k2yz7vv6mpamnn9xhd0/appointments
https://find-and-update.company-information.service.gov.uk/company/06498279/officers
https://find-and-update.company-information.service.gov.uk/officers/dzlfkzuewhlsgqsex8yynyex1dy/appointments
https://*********************/newsfeed/article/proposed-acquisition-and-capital-raising-671971
Does Nigel ever read this board.
He and his directors should buy shares.